TZ Ref No.: TZ-26-1912758
STEM-SAFE - Translating a Multi-Organ NAM into an Industrial Standard for Safety Assessment of Hematopoietic Stem Cell-Based Gene Therapies
Doc ref no.
1013•••
Sector
Services
Contract Date
06 Jul 2026
Contract Value
EUR ••••••
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Official Award Result
Status: Contract Awarded
Award Date: 06 Jul 2026
Awarded Contractor / Winner
FOND•••
Awarded Contract Value:
EUR 300,000.00
Execution Period:
01 Sep 2026 → 31 May 2027
(272 days)
Contract Description
Gene therapies (GTs) based on hematopoietic stem and progenitor cells (HSPCs) hold great promise, but their tumorigenicity risk, already observed in patients, is a significant concern. Current safety tests rely on oversimplified in vitro systems, often based on murine cells...